Wealth Enhancement Advisory Services LLC Acquires 1,941 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Wealth Enhancement Advisory Services LLC increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,504 shares of the exchange traded fund’s stock after acquiring an additional 1,941 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in SPDR S&P Biotech ETF were worth $11,906,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of XBI. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF during the third quarter worth about $141,284,000. Affinity Asset Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 105.4% during the second quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after acquiring an additional 737,550 shares in the last quarter. Assetmark Inc. boosted its stake in SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after acquiring an additional 588,489 shares in the last quarter. Finally, Sivik Global Healthcare LLC bought a new position in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $29,640,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $89.44 on Monday. The firm’s 50 day moving average price is $95.48 and its 200-day moving average price is $97.12. The company has a market cap of $6.82 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.